Description
William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital is joined by guest Amin Al-Ahmad, MD, FHRS, CCDS, Texas Cardiac Arrhythmia Institute and Jorge Romero, Jr., MD, FHRS, Brigham and Women's Hospital to discuss how Pulsed-field ablation (PFA) is a novel nonthermal ablation technology with high procedural safety and efficiency for pulmonary vein isolation (PVI). Premarket data showed high PVI durability during mandatory remapping studies. Data on lesion durability in real-world patients with clinically indicated redo procedures are scarce. In this episode of The Lead, we discuss why and how this study sought to report PVI durability rates in patients undergoing a clinically indicated redo procedure after an index PVI using PFA.
Learning Objectives
- To discuss the study, "Durability of Pulmonary Vein Isolation Using Pulsed-Field Ablation," and it's objectives, methods, results, conclusions, and limitations.
Article Authors and Podcast Contributors
Article Authors
Thomas Kueffer, MSC, Stefano Bordignon, MD, Kars Neven, MD, PHD, Yuri Blaauw, MD, Jim Hansen, MD, Raquel Adelino, MD, Alexandre Ouss, MD, Anna Füting, MD, Laurent Roten, MD, Bart A. Mulder, MD, PHD, Martin H. Ruwald, MD, PHD, Roberto Mené, MD, Pepijn van der Voort, MD, Nico Reinsch, MD, Serge Boveda, MD, PHD Elizabeth M. Albrecht, PHD, Christopher W. Schneider, MSC, K.R. Julian Chun, MD, Boris Schmidt, MD, Tobias Reichlin, MD
Podcast Contributors
William H. Sauer, MD, FHRS, CCDS, Brigham and Women's Hospital
Amin Al-Ahmad, MD, FHRS, CCDS, Texas Cardiac Arrhythmia Institute
Jorge Romero, Jr., MD, FHRS, Brigham and Women's Hospital
Faculty and Disclosures
All relevant financial relationships have been mitigated.
Host Disclosure(s):
W. Sauer: Honoraria/Speaking/Consulting: Biotronik, Biosense Webster, Inc., Abbott, Boston Scientific, Research: Medtronic
Contributor Disclosure(s):
A. Al-Ahmad: Honoraria/Speaking/Consulting: Abbott, Biosense Webster, Inc., Boston Scientific, Haemonetics, Mediasphere Medical, Medtronic, Philips, Stocks, Privately Held: Soundcath
J. Romero: Honoraria/Speaking/Consulting: Sanofi, Boston Scientific, AtriCure, Inc.
Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.